Aimee L. Pierce, M.D.

Director of Clinical Care and Therapeutics Associate Professor of Neurology

Oregon Health & Science University

Affiliations

OHSU School of Medicine

Center Of Layton Aging And Alzheimer'S Disease

Department Of Pediatrics

Division Of Neurology

Oregon Health & Science University

Aimee L. Pierce, M.d. is currently serving as a Center Of Layton Aging And Alzheimer'S Disease Director of Clinical Care and Therapeutics Associate Professor of Neurology at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Aimee L. Pierce, M.D.

Oregon Health & Science University

Director of Clinical Care and Therapeutics Associate Professor of Neurology

You can click a keyword to filter the displayed items

alzheimer's disease neuroscience neurology dementia neurodegenerative diseases medicine cognitive impairment public health clinical trials medicinal research neuroscience of aging clinical research molecular neurodegeneration aging-associated diseases neuroimaging diagnosis experimental medicine disease diagnosis alzheimer disease amyloid imaging protein science psychological medicine psychiatric research translational psychiatry biomedical informatics molecular diagnostics digital medicine family practice supportive care molecular psychiatry student retention multiset data analysis geriatric medicine elderly care later adulthood prognosis protein misfolding frontotemporal dementia clinical neurology treatment options medical diagnosis memory loss drug trials attitude theory neurochemistry brain imaging patient satisfaction psychiatric disorders neuropsychiatry suicide psychiatric diseases clinical translation disease assessment clinical neuroscience disease detection geriatric neurology neurochemical biomarkers clinical gerontology geriatric assessment change detection model-guided microarray retromer complex genetic risk factors chinese population immune system disease pathogenesis late-onset alzheimer disease statistical tests identifiability conditions multisite datasets early alzheimer clinical diagnosis placebo-controlled trial early alzheimer disease chronic diseases neuropsychological rehabilitation neuroradiology geriatrics medical history individualized medicine translational research parkinson's disease geriatric psychiatry neuropsychology health sciences neurorehabilitation mortality child neurology pediatrics world psychiatry psychiatry neurodevelopmental disorders movement disorders clinical epidemiology neuropathology jama psychiatry internal medicine attention disorders

Notable Scholarly Works

Notable Federal Grants

Collaborators

Detect‐Ad (Digital Evaluations and Technologies Enabling Clinical Translation for Alzheimer’s Disease): Baseline Results of a Simulated Anti‐Amyloid Clinical Trial Using Digital Biomarkers. Alzheimer s & Dementia (2025)

neurologyneuroscience of agingalzheimer's diseasebaseline resultsmolecular neurodegenerationdigital biomarkersneuroscienceneurodegenerative diseasesaging-associated diseasesdigital evaluationsneurochemical biomarkersbiomarkers

Disclosure of Elevated Amyloid Status is Not Associated With Long‐Term Suicidality in a Preclinical Ad Trial. Alzheimer s & Dementia (2025)

post-traumatic stress disorderpsychiatric disorderspsychological medicineneuropsychiatrypsychiatric researchamyloid statuspsychologylong‐term suicidalityalzheimer's diseaseneurodegenerative diseasesdementiasuicidepsychiatric diseasestranslational psychiatrypsychopathologyneurologyneuroscience of agingpsychiatrypreclinical ad trialdepression

The Neighborhoods Study: Examining the Social Exposome in Alzheimer's Disease and Related Dementias. Alzheimer s & Dementia (2025)

neuroscience of agingalzheimer's diseasegeriatric neurologydementiasociology

Detect‐Ad ‐ Digital Evaluations and Technologies Enabling Clinical Translation for Alzheimer’s Disease: Results of Amyloid Screening Methodologies in a Simulated Anti‐Amyloid Clinical Trial Using Digital Biomarkers as Primary Outcome Measures. Alzheimer s & Dementia (2024)

Jeffrey A KayeNora MattekAmanda B MarJennifer MarcoeElise J HannaAimee PierceYanan ShangKirsten M WrightJonathan A WyattDaniel SchwartzSarah GothardWan‐Tai M. Au‐YeungJoel S. SteeleZachary T BeattieKevin DuffLisa C Silbert

alzheimer's diseasedigital biomarkersclinical trialsprimary outcome measureshealth sciences

Maternal Allergen Exposure During Fetal Development Disrupts Parasympathetic Nerve Development in Murine Offspring. (2024)

Over‐Representation of Extremely Wealthy Neighborhood Social Exposomes for Brain Donors Within Alzheimer’s Disease Research Center Brain Banks Assessed by the Neighborhoods Study. Alzheimer s & Dementia (2024)

Amy J.H. KindBarbara B. BendlinW. Ryan PowellAmanda DeWittYixuan ChengLuke ChamberlainJessica SharrowBrittney Lyons BooneErin L. AbnerMichael L. AloscoLiana G. ApostolovaKelly M. BakulskiLisa L. BarnesJames R. BatemanThomas G. BeachDavid A. BennettJames B. BrewerCarmen CarrionJoshua ChodoshSuzanne CraftRaina CroffAnthony FabioSarah Tomaszewski FariasFelicia GoldsteinVictor W. HendersonThomas K KarikariJulia KoflerAnna M. Kucharska‐NewtonMelissa LamarSerggio LanataRebecca J LeppingJennifer H LinglerSamuel N. LockhartJonathan D MahnkenKaryn MarshOanh L. MeyerBruce L. MillerJill K MorrisJudith A. NeugroschlMaureen K. O'ConnorHenry L PaulsonRichard J. PerrinCorinne PettigrewAimee PierceCyrus A. RajiEric M. ReimanShannon L. RisacherRobert A RissmanPatricia Rodriguez EspinozaMary SanoAndrew J. SaykinGeidy E SerranoAnja SoldanDavid L SultzerRachel A. WhitmerThomas WisniewskiRandall WoltjerCarolyn W. Zhu

brain donorsalzheimer's diseasesocial sciencesdementianeighborhoods study

Phase 2A Proof-Of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease. Neurology (2024)

Joshua D. GrillSteven TamGaby ThaiBeatriz VidesAimee L. PierceKim GreenDaniel L. GillenEdmond TengSarah KremenMaryam BeigiRobert A. RissmanGabriel C. LégerArchana BalasubramanianCarolyn RevtaRosemary MorrisonRobin JenningsJudy PaJing ZhangShelia JinKaren MesserHoward H. Feldman

biostatisticsneurologyalzheimer's diseasememory lossplacebo-controlled trialmedicinal researchdrug trialsneurodegenerative diseasescognitive impairmentearly alzheimer diseasepharmacologydementiaproof-of-concept double-blindclinical trials

Stop! in the Name of (Light): Using Optogenetics to Define the Role of Parasympathetic Nerves in Allergen-Induced Airway Hyperresponsiveness. (2024)

The African American Dementia and Aging Project: An Oregon-Based Longitudinal Study. Frontiers in Dementia (2024)

Allison LindauerRaina CroffKevin DuffNora MattekPatrice FullerAimee PierceKalisha Bonds JohnsonJeffrey Kaye

oregon-based longitudinal studylongitudinal studiesafrican american studiesaging-associated diseasesafrican american dementiadementia

An Analysis of Factors Influencing Dementia Study Enrollment: Focus Groups With Diverse Community Members Viewing the Actnow Research Registry Website. Alzheimer s & Dementia (2023)

health policyhealth services researchdementia study enrollmentfocus groupsfamily practiceclinical gerontologynursinggeriatric assessmentimplementation researchdiverse community membersdementiasupportive carefamily medicinecommunity-engaged research